Tower Research Capital (TRC)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2K | Sell |
|
|||||
|
2025
Q1 | $37.7K | Buy |
|
|||||
|
2024
Q4 | $16.3K | Sell |
|
|||||
|
2024
Q3 | $534K | Buy |
|
|||||
|
2024
Q2 | $50.4K | Buy |
|
|||||
|
2024
Q1 | $16.4K | Buy |
|
|||||
|
2023
Q4 | $3.71K | Sell |
|
|||||
|
2023
Q3 | $38.6K | Buy |
|
|||||
|
2023
Q2 | $1.56K | Sell |
|
|||||
|
2023
Q1 | $23K | Buy |
|
|||||
|
2022
Q4 | $19K | Sell |
|
|||||
|
2022
Q3 | $28K | Sell |
|
|||||
|
2022
Q2 | $46K | Sell |
|
|||||
|
2022
Q1 | $190K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $61K | Sell |
|
|||||
|
2021
Q2 | $278K | Buy |
|
|||||
|
2021
Q1 | $148K | Sell |
|
|||||
|
2020
Q4 | $430K | Buy |
|
|||||
|
2020
Q3 | $257K | Buy |
|
|||||
|
2020
Q2 | $11K | Sell |
|
|||||
|
2020
Q1 | $194K | Buy |
|
|||||
|
2019
Q4 | $172K | Buy |
|
|||||
|
2019
Q3 | $2K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $125K | Sell |
|
|||||
|
2018
Q4 | $586K | Buy |
|
|||||
|
2018
Q3 | $84K | Buy |
|
|||||
|
2018
Q2 | $20K | Sell |
|
|||||
|
2018
Q1 | $28K | Buy |
|
|||||
|
2017
Q4 | $4K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $3K | Sell |
|
|||||
|
2017
Q1 | $4K | Sell |
|
|||||
|
2016
Q4 | $83K | Sell |
|
|||||
|
2016
Q3 | $345K | Buy |
|
|||||
|
2016
Q2 | $33K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $40K | Buy |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $42K | Buy |
|
|||||
|
2014
Q1 | $9K | Sell |
|
|||||
|
2013
Q4 | $504K | Buy |
|
|||||
|
2013
Q3 | $16K | Buy |
|
|||||
|
2013
Q2 | $6K | Buy |
|